🇺🇸 FDA
Patent

US 7960385

Guanidine-containing compounds useful as muscarinic receptor antagonists

granted A61PA61P1/04A61P1/12

Quick answer

US patent 7960385 (Guanidine-containing compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P1/04, A61P1/12, A61P11/00, A61P11/02